Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - molnupiravir -

New Zealand - English - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - remdesivir 100mg (approx 5% overfill);   - powder for injection - 100 mg - active: remdesivir 100mg (approx 5% overfill)   excipient: betadex hydrochloric acid sodium hydroxide - veklury is indicated for the treatment of coronavirus disease 2019 (covid-19) in: - adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) who have pneumonia due to sars-cov-2, and who require supplemental oxygen. - adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at high risk of progressing to severe covid-19.

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - molnupiravir 200mg;  ;  ;   - capsule - 200 mg - active: molnupiravir 200mg       excipient: croscarmellose sodium hyprolose hypromellose ink iron oxide red magnesium stearate microcrystalline cellulose titanium dioxide - lagevrio is indicated for the treatment of mild to moderate coronavirus disease 2019 (covid-19) in adults aged 18 years and older who are at increased risk of progressing to severe covid-19, hospitalisation or death.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

mylan pharmaceuticals (pty) ltd - powder - 100,0 mg - each vial contains remdesivir 100,0 mg

United States - English - NLM (National Library of Medicine)

eli lilly and company - baricitinib (unii: isp4442i3y) (baricitinib - unii:isp4442i3y) -

Canada - English - Health Canada

pfizer canada ulc - ritonavir; nirmatrelvir - tablet - 100mg; 150mg - ritonavir 100mg; nirmatrelvir 150mg

Canada - English - Health Canada

pfizer canada ulc - ritonavir; nirmatrelvir - tablet - 100mg; 150mg - ritonavir 100mg; nirmatrelvir 150mg

Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - tocilizumab - infusion, solution concentrate - 20mg/ml - tocilizumab 20mg/ml

European Union - English - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - anakinra - arthritis, rheumatoid; covid-19 virus infection - immunosuppressants - rheumatoid arthritis (ra)kineret is indicated in adults for the treatment of the signs and symptoms of ra in combination with methotrexate, with an inadequate response to methotrexate alone.covid-19kineret is indicated for the treatment of coronavirus disease 2019 (covid-19) in adult patients with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) who are at risk of progressing to severe respiratory failure determined by plasma concentration of soluble urokinase plasminogen activator receptor (supar) ≥ 6 ng/ml.periodic fever syndromeskineret is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above:cryopyrin-associated periodic syndromes (caps)kineret is indicated for the treatment of caps, including:neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca)muckle-wells syndrome (mws)familial cold autoinflammatory syndrome (fcas)familial mediterranean fever (fmf)kineret is indicated for the treatment of familial mediterranean fever (fmf). kineret should be given in combination with colchicine, if appropriate.still’s diseasekineret is indicated in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above for the treatment of still’s disease, including systemic juvenile idiopathic arthritis (sjia) and adult-onset still’s disease (aosd), with active systemic features of moderate to high disease activity, or in patients with continued disease activity after treatment with non-steroidal anti-inflammatory drugs (nsaids) or glucocorticoids.kineret can be given as monotherapy or in combination with other anti-inflammatory drugs and disease-modifying antirheumatic drugs (dmards).

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

roche (malaysia) sdn. bhd. - tocilizumab -